Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03190889 · ClinicalTrials.gov registry record · NA

Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT03190889: Completed NA study, sponsored by Mayo Clinic.

NCT03190889 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03190889, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The overall goal of this project is to reduce risk of second anterior cruciate ligament (ACL) injury in vulnerable populations (active athletes between 14 = 24 years old) through the identification of relative injury risk groups based on subject-specific movement patterns prior to second injury, as well as through the determination of effect for differential rehabilitation protocols following initial ACL reconstruction and prior to return to sport. As nearly one-third of athletes who have a primary ACL injury and return to sport will experience a secondary injury, results from the proposed work will allow us to prospectively identify high risk patients who are the most appropriate recipients of enhanced treatment, including targeted training, which may reduce the risk of second ACL injury. Secondary ACL injury has the potential to end athletic careers, promote the development of osteoarthritis, and have debilitating effects on quality of life. Hence, the information gathered in this investigation will offer ACL injured athletes the optimal potential to reduce or potentially prevent these negative health effects before they are initiated.

Interventions

  • OTHER HOME
  • OTHER TNMT

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2018-08-01
Est. Completion 2024-06-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03190889

The ClinicalTrials.gov registry entry for NCT03190889 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which HOME is the first listed.

NCT03190889 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03190889 about?

NCT03190889 is a clinical study titled "Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes". The overall goal of this project is to reduce risk of second anterior cruciate ligament (ACL) injury in vulnerable populations (active athletes between 14 = 24 years old) through the identification of relative injury risk groups based on subject-specific movement patterns prior to second injury, as ...

What is the current status of trial NCT03190889?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2018-08-01. Estimated completion is 2024-06-30.

What interventions are being tested in trial NCT03190889?

The interventions under investigation include: HOME (OTHER), TNMT (OTHER).

Who is sponsoring clinical trial NCT03190889?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.